Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts Antimalarial Activity
Overview
Affiliations
The peroxide bond of the artemisinins inspired the development of a class of fully synthetic 1,2,4-trioxolane-based antimalarials, collectively known as the ozonides. Similar to the artemisinins, heme-mediated degradation of the ozonides generates highly reactive radical species that are thought to mediate parasite killing by damaging critical parasite biomolecules. We examined the relationship between parasite dependent degradation and antimalarial activity for two ozonides, OZ277 (arterolane) and OZ439 (artefenomel), using a combination of drug stability and pulsed-exposure activity assays. Our results showed that drug degradation is parasite stage dependent and positively correlates with parasite load. Increasing trophozoite-stage parasitemia leads to substantially higher rates of degradation for both OZ277 and OZ439, and this is associated with a reduction in antimalarial activity. Under conditions of very high parasitemia (∼90%), OZ277 and OZ439 were rapidly degraded and completely devoid of activity in trophozoite-stage parasite cultures exposed to a 3-h drug pulse. This study highlights the impact of increasing parasite load on ozonide stability and antimalarial activity and should be considered when investigating the antimalarial mode of action of the ozonide antimalarials under conditions of high parasitemia.
Total Synthesis of Tosyl-Samroiyotmycin A and Its Biological Profiling.
Kolb B, Schmid F, Weng J, Altevogt L, Pereira Rebelo R, Wank B Chemistry. 2024; 30(71):e202403408.
PMID: 39348488 PMC: 11653242. DOI: 10.1002/chem.202403408.
Characterization of antimalarial activity of artemisinin-based hybrid drugs.
Quadros H, Herrmann L, Manaranche J, Paloque L, Borges-Silva M, Dziwornu G Antimicrob Agents Chemother. 2024; 68(7):e0014324.
PMID: 38899927 PMC: 11232401. DOI: 10.1128/aac.00143-24.
Herrmann L, Leidenberger M, Sacramento de Morais A, Mai C, Capci A, da Cruz Borges Silva M Chem Sci. 2023; 14(45):12941-12952.
PMID: 38023498 PMC: 10664590. DOI: 10.1039/d3sc03661h.
Walz A, Duffey M, Aljayyoussi G, Sax S, Leroy D, Besson D Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37009844 PMC: 9959027. DOI: 10.3390/ph16020163.
Du Y, Giannangelo C, He W, Shami G, Zhou W, Yang T Antimicrob Agents Chemother. 2022; 66(5):e0206521.
PMID: 35416709 PMC: 9112877. DOI: 10.1128/aac.02065-21.